A citation-based method for searching scientific literature

Nina Weisshaar, Jingxia Wu, Yanan Ming, Alaa Madi, Agnes Hotz-Wagenblatt, Sicong Ma, Alessa Mieg, Marvin Hering, Ferdinand Zettl, Kerstin Mohr, Tilo Schlimbach, Nora Ten Bosch, Franziska Hertel, Lisann Müller, Hannah Byren, Mona Wang, Helena Borgers, Mareike Munz, Lukas Schmitt, Franciscus van der Hoeven, Ulrich Kloz, Rafael Carretero, Nikolai Schleußner, Rene-Filip Jackstadt, Ilse Hofmann, Guoliang Cui. Sci Immunol 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non-Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease.
Weili Wang, Lei Huang, Jian-Yue Jin, Wenhu Pi, Susannah G Ellsworth, Shruti Jolly, Andrew L Mellor, Mitchell Machtay, Feng-Ming Spring Kong. Clin Cancer Res 2020
13
50

Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics.
Sophia K Longo, Margaret G Guo, Andrew L Ji, Paul A Khavari. Nat Rev Genet 2021
101
50

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A Chan, George Coukos, Sandra Demaria, Eric Deutsch,[...]. J Immunother Cancer 2020
288
50

A review of cancer immunotherapy toxicity.
Lucy Boyce Kennedy, April K S Salama. CA Cancer J Clin 2020
337
50

Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint.
Nathalie M Schmidt, Peter A C Wing, Mariana O Diniz, Laura J Pallett, Leo Swadling, James M Harris, Alice R Burton, Anna Jeffery-Smith, Nekisa Zakeri, Oliver E Amin,[...]. Nat Commun 2021
15
50

High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39+CD8+ T cells.
Ting Liu, Jizhou Tan, Minhao Wu, Wenzhe Fan, Jialiang Wei, Bowen Zhu, Jian Guo, Shutong Wang, Penghui Zhou, Hui Zhang,[...]. Gut 2021
29
50

Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Jin-Ching Lin, Kuang Y Chen, Wen-Yi Wang, Jian-Sheng Jan, Wen-Miin Liang, Yau-Huei Wei. Int J Cancer 2002
16
50

Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response.
Alexander Haragan, John K Field, Michael P A Davies, Carles Escriu, Aaron Gruver, John R Gosney. Lung Cancer 2019
66
50

Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway.
Vesselina G Cooke, Valerie S LeBleu, Doruk Keskin, Zainab Khan, Joyce T O'Connell, Yingqi Teng, Michael B Duncan, Liang Xie, Genta Maeda, Sylvia Vong,[...]. Cancer Cell 2012
369
50


Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.
Kevin C Conlon, Enrico Lugli, Hugh C Welles, Steven A Rosenberg, Antonio Tito Fojo, John C Morris, Thomas A Fleisher, Sigrid P Dubois, Liyanage P Perera, Donn M Stewart,[...]. J Clin Oncol 2015
399
50

Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Masato Nakamura, Hiroaki Nagano, Masato Sakon, Tameyoshi Yamamoto, Hideo Ota, Hiroshi Wada, Bazarragchaa Damdinsuren, Takehiro Noda, Shigeru Marubashi, Atsushi Miyamoto,[...]. J Hepatol 2007
58
50

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC.
David R Spigel, Jamie E Chaft, Scott Gettinger, Bo H Chao, Luc Dirix, Peter Schmid, Laura Q M Chow, Rodney J Hicks, Larry Leon, Jill Fredrickson,[...]. J Thorac Oncol 2018
78
50


Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models.
Nicholas L Syn, Pei Li Lim, Li Ren Kong, Lingzhi Wang, Andrea Li-Ann Wong, Chwee Ming Lim, Thomas Kwok Seng Loh, Gerhard Siemeister, Boon Cher Goh, Wen-Son Hsieh. Signal Transduct Target Ther 2018
24
50

CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours.
Zahra Madjd, Ali Zare Mehrjerdi, Ali Mohammad Sharifi, Saadat Molanaei, Shahriar Zohourian Shahzadi, Mohsen Asadi-Lari. Cancer Immun 2009
72
50

Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies.
Rodolfo Daniel Cervantes-Villagrana, Damaris Albores-García, Alberto Rafael Cervantes-Villagrana, Sara Judit García-Acevez. Signal Transduct Target Ther 2020
52
50

Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.
Terence Kin-Wah Lee, Xin-Yuan Guan, Stephanie Ma. Nat Rev Gastroenterol Hepatol 2022
31
50

Next generation of immune checkpoint inhibitors and beyond.
Julian A Marin-Acevedo, ErinMarie O Kimbrough, Yanyan Lou. J Hematol Oncol 2021
77
50

TOX is a critical regulator of tumour-specific T cell differentiation.
Andrew C Scott, Friederike Dündar, Paul Zumbo, Smita S Chandran, Christopher A Klebanoff, Mojdeh Shakiba, Prerak Trivedi, Laura Menocal, Heather Appleby, Steven Camara,[...]. Nature 2019
388
50

TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.
Omar Khan, Josephine R Giles, Sierra McDonald, Sasikanth Manne, Shin Foong Ngiow, Kunal P Patel, Michael T Werner, Alexander C Huang, Katherine A Alexander, Jennifer E Wu,[...]. Nature 2019
494
50

Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy.
Kai Tang, Ya-Hong Wu, Yihui Song, Bin Yu. J Hematol Oncol 2021
44
50

Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment.
James L Gulley, Jeffrey Schlom, Mary Helen Barcellos-Hoff, Xiao-Jing Wang, Joan Seoane, Francois Audhuy, Yan Lan, Isabelle Dussault, Aristidis Moustakas. Mol Oncol 2022
8
50

T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy.
Jin Bian, Jianzhen Lin, Junyu Long, Xu Yang, Xiaobo Yang, Xin Lu, Xinting Sang, Haitao Zhao. Am J Cancer Res 2020
16
50

Changes of circulating transforming growth factor-beta1 level during radiation therapy are correlated with the prognosis of locally advanced non-small cell lung cancer.
Lujun Zhao, Wei Ji, Li Zhang, Guangfei Ou, Qinfu Feng, Zongmei Zhou, Mingfang Lei, Weizhi Yang, Luhua Wang. J Thorac Oncol 2010
29
50

High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients.
Ana Koren, Matija Rijavec, Eva Sodja, Izidor Kern, Aleksander Sadikov, Viljem Kovac, Peter Korosec, Tanja Cufer. Oncotarget 2017
4
50

Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy.
Satyen H Gohil, J Bryan Iorgulescu, David A Braun, Derin B Keskin, Kenneth J Livak. Nat Rev Clin Oncol 2021
54
50

SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges.
Yu Chen, Min Gao, Zhaoqin Huang, Jinming Yu, Xiangjiao Meng. J Hematol Oncol 2020
26
50

The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Liu Li, Qiu Guo Chao, Liu Zhong Ping, Chen Xue, Zhao Yan Xia, Ding Qian, Huang Shi-ang. Cancer Biother Radiopharm 2009
33
50

Trajectory and Functional Analysis of PD-1high CD4+CD8+ T Cells in Hepatocellular Carcinoma by Single-Cell Cytometry and Transcriptome Sequencing.
Bo Zheng, Dongfang Wang, Xinyao Qiu, Guijuan Luo, Tong Wu, Shuai Yang, Zhixuan Li, Yanjing Zhu, Shan Wang, Rui Wu,[...]. Adv Sci (Weinh) 2020
26
50

Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.
Tae Kon Kim, Esten N Vandsemb, Roy S Herbst, Lieping Chen. Nat Rev Drug Discov 2022
3
50

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Yang Hao, David Baker, Peter Ten Dijke. Int J Mol Sci 2019
365
50

Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Guoying Zhou, Dave Sprengers, Patrick P C Boor, Michail Doukas, Hannah Schutz, Shanta Mancham, Alexander Pedroza-Gonzalez, Wojciech G Polak, Jeroen de Jonge, Marcia Gaspersz,[...]. Gastroenterology 2017
218
50

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.
Ashley Maynard, Caroline E McCoach, Julia K Rotow, Lincoln Harris, Franziska Haderk, D Lucas Kerr, Elizabeth A Yu, Erin L Schenk, Weilun Tan, Alexander Zee,[...]. Cell 2020
130
50

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Filipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, Faiza Lamine, Michel Maillard, Montserrat Fraga, Keyvan Shabafrouz, Camillo Ribi, Anne Cairoli, Yan Guex-Crosier,[...]. Nat Rev Clin Oncol 2019
634
50

Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
Shulian Wang, Jeff Campbell, Matthew H Stenmark, Jing Zhao, Paul Stanton, Martha M Matuszak, Randall K Ten Haken, Feng-Ming Spring Kong. Int J Radiat Oncol Biol Phys 2017
34
50

Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses.
Karsten A Pilones, Maud Charpentier, Elena Garcia-Martinez, Camille Daviaud, Jeffrey Kraynak, Joseph Aryankalayil, Silvia C Formenti, Sandra Demaria. Cancer Immunol Res 2020
13
50

Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer.
Juliana Matiello, Alan Dal Pra, Laise Zardo, Ricardo Silva, Danilo C Berton. Thorac Cancer 2020
7
50

Emerging agents that target signaling pathways in cancer stem cells.
Yue Yang, Xiaoman Li, Ting Wang, Qianqian Guo, Tao Xi, Lufeng Zheng. J Hematol Oncol 2020
56
50

Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer.
Edwin Pun Hui, Brigette B Y Ma, W K Jacky Lam, K C Allen Chan, Frankie Mo, Qi-Yong Hemis Ai, Ann D King, Chi Hang Wong, Kenneth C W Wong, Daisy C M Lam,[...]. Clin Cancer Res 2021
8
50


The Next Decade of Immune Checkpoint Therapy.
Padmanee Sharma, Bilal A Siddiqui, Swetha Anandhan, Shalini S Yadav, Sumit K Subudhi, Jianjun Gao, Sangeeta Goswami, James P Allison. Cancer Discov 2021
100
50


Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
Yanan Gao, Maojun You, Junliang Fu, Meijie Tian, Xinyue Zhong, Chengzhi Du, Zhixian Hong, Zhenyu Zhu, Junliang Liu, Geoffrey J Markowitz,[...]. J Hepatol 2022
18
50

Metastatic cells will take any help they can get.
Richard O Hynes. Cancer Cell 2011
9
50

Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression.
Yanmei Han, Qiuyan Liu, Jin Hou, Yan Gu, Yi Zhang, Zhubo Chen, Jia Fan, Weiping Zhou, Shuangjian Qiu, Yonghong Zhang,[...]. Cell 2018
71
50

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
T Lapidot, C Sirard, J Vormoor, B Murdoch, T Hoang, J Caceres-Cortes, M Minden, B Paterson, M A Caligiuri, J E Dick. Nature 1994
50

Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis.
Sophia Heinrich, Amanda J Craig, Lichun Ma, Bernd Heinrich, Tim F Greten, Xin W Wang. J Hepatol 2021
21
50

RNA m6 A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy.
Ziyou Lin, Yi Niu, Arabella Wan, Dongshi Chen, Heng Liang, Xijun Chen, Lei Sun, Siyue Zhan, Liutao Chen, Chao Cheng,[...]. EMBO J 2020
133
50

Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade.
Youhai Jiang, Xiaofang Zhao, Jing Fu, Hongyang Wang. Front Immunol 2020
41
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.